AP2002002496A0 - Method and compositions for treating pulmonary diseases. - Google Patents

Method and compositions for treating pulmonary diseases.

Info

Publication number
AP2002002496A0
AP2002002496A0 APAP/P/2002/002496A AP2002002496A AP2002002496A0 AP 2002002496 A0 AP2002002496 A0 AP 2002002496A0 AP 2002002496 A AP2002002496 A AP 2002002496A AP 2002002496 A0 AP2002002496 A0 AP 2002002496A0
Authority
AP
ARIPO
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
APAP/P/2002/002496A
Other languages
English (en)
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AP2002002496A0 publication Critical patent/AP2002002496A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/2002/002496A 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases. AP2002002496A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
AP2002002496A0 true AP2002002496A0 (en) 2002-06-30

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002496A AP2002002496A0 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases.

Country Status (29)

Country Link
EP (1) EP1225866A4 (no)
JP (1) JP2003513028A (no)
KR (1) KR20020057988A (no)
CN (1) CN1387404A (no)
AP (1) AP2002002496A0 (no)
AR (1) AR029189A1 (no)
AU (1) AU1357501A (no)
BG (1) BG106748A (no)
BR (1) BR0015270A (no)
CA (1) CA2388333A1 (no)
CO (1) CO5261512A1 (no)
CZ (1) CZ20021512A3 (no)
DZ (1) DZ3225A1 (no)
EA (1) EA200200518A1 (no)
EC (1) ECSP003747A (no)
HK (1) HK1049107A1 (no)
HU (1) HUP0203152A3 (no)
IL (1) IL149367A0 (no)
MA (1) MA26841A1 (no)
MX (1) MXPA02004350A (no)
NO (1) NO20022057L (no)
OA (1) OA12076A (no)
PE (1) PE20011005A1 (no)
PL (1) PL355261A1 (no)
SK (1) SK7592002A3 (no)
TR (1) TR200201211T2 (no)
TW (1) TWI242431B (no)
WO (1) WO2001032127A2 (no)
ZA (1) ZA200203435B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2459757C (en) * 2001-09-19 2011-08-30 Altana Pharma Ag Combination
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
WO2004087149A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co. Ltd. 医薬組成物
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7174794A (en) * 1993-06-18 1995-01-17 Smithkline Beecham Corporation Compounds
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
EP1225866A4 (en) 2004-04-21
CN1387404A (zh) 2002-12-25
AR029189A1 (es) 2003-06-18
WO2001032127A3 (en) 2001-12-06
TWI242431B (en) 2005-11-01
PL355261A1 (en) 2004-04-05
OA12076A (en) 2006-05-04
JP2003513028A (ja) 2003-04-08
IL149367A0 (en) 2002-11-10
HK1049107A1 (zh) 2003-05-02
PE20011005A1 (es) 2001-09-28
NO20022057D0 (no) 2002-04-30
ECSP003747A (es) 2002-05-23
CO5261512A1 (es) 2003-03-31
AU1357501A (en) 2001-05-14
CZ20021512A3 (cs) 2003-04-16
SK7592002A3 (en) 2002-11-06
CA2388333A1 (en) 2001-05-10
KR20020057988A (ko) 2002-07-12
WO2001032127A2 (en) 2001-05-10
NO20022057L (no) 2002-06-27
EA200200518A1 (ru) 2002-10-31
MXPA02004350A (es) 2002-11-07
HUP0203152A3 (en) 2004-06-28
BG106748A (en) 2003-02-28
MA26841A1 (fr) 2004-12-20
HUP0203152A2 (hu) 2003-01-28
TR200201211T2 (tr) 2002-08-21
DZ3225A1 (fr) 2001-05-10
BR0015270A (pt) 2002-06-18
EP1225866A2 (en) 2002-07-31
ZA200203435B (en) 2003-06-25

Similar Documents

Publication Publication Date Title
MY126544A (en) Therapies for treating pulmonary diseases
MXPA04000793A (es) Novedoso metodo terapeutico.
MXPA02011311A (es) Composicion novedosa.
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
PL1663185T3 (pl) Zapobieganie i leczenie utraty kości wywołanej przez zapalenie i/lub za pośrednictwem układu odpornościowego
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
LT2004060A (en) A composition for treating neurocerebrovascular disorders
WO2002088101A3 (en) Inhibitors of bace
MXPA04000328A (es) Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer.
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
MXPA04000338A (es) Diamindioles para tratamiento de enfermedad de alzheimer.
MXPA04002785A (es) Aminas sustituidas para tratamiento de enfermedad de alzheimer.
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
AP2002002496A0 (en) Method and compositions for treating pulmonary diseases.
WO2002100818A3 (en) Aminediols as agents for the treatment of alzheimer's disease
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
SE9900833D0 (sv) Novel combination
HK1018265A1 (en) Piperazino derivatives as neurokinin antagonists
PL323235A1 (en) Derivatives of piperazine as neurokinin antagonists
BG105953A (en) Method for treating copd
SE9900834D0 (sv) Novel combination
MXPA04000337A (es) Amindioles para tratamiento de enfermedad de alzheimer.
MY130725A (en) Composition and method for treating allergic diseases
HU9603540D0 (en) Substituted alkyldiamine derivatives and their use as tachykinin antagonists